IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
IDEAYA Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$33.81+0.96 (+2.92%)
Close on Oct 19, 2026
- Market cap
- $3.11B
- P/E (TTM)
- –
- Dividend yield
- –
IDEAYA Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Market Cap | $3.26B | $197.05M |
| Enterprise Value | $2.43B | $106.56M |
| PS Ratio | 13.93 | 3.93 |
| PB Ratio | 2.72 | 2.14 |
| P/TBV Ratio | 2.72 | 2.46 |
Enterprise value
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| EV / Sales | 10.39 | 2.69 |
Income (trailing twelve months)
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Revenue | $234.13M | $57.94M |
| Operating Income | -$216.95M | -$21.44M |
| Net Income | -$175.02M | -$22.46M |
| EBITDA | -$214.14M | -$16.91M |
| EPS (Diluted) | -$1.94 | -$0.83 |
Margins
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Operating Margin | -92.7% | -44.5% |
| Profit Margin | -74.8% | -39.2% |
| EBITDA Margin | -91.5% | -31.3% |
| FCF Margin | -48.6% | -8.85% |
Returns
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -16.2% | -53.1% |
| Return on Assets (ROA) | -14.9% | -41.0% |
| Return on Invested Capital (ROIC) | -51.9% | -32.0% |
| Return on Capital Employed (ROCE) | -17.7% | -37.8% |
Growth
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | 62.5% | 2.25% |
| Revenue Growth (5Y CAGR) | 62.1% | 6.42% |
Balance sheet
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $828.96M | $62.42M |
| Net Cash (Debt) | $828.96M | $15.68M |
| Net Cash Per Share | $8.59 | $0.65 |
| Equity (Book Value) | $1.20B | $48.79M |
| Book Value Per Share | $12.43 | $1.36 |
| Tangible Book Value | $1.20B | $23.06M |
| Working Capital | $781.35M | $75.77M |
Financial position
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Current Ratio | 10.45 | 3.30 |
| Quick Ratio | 10.03 | 2.39 |
Cash flow (trailing twelve months)
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$111.66M | -$12.35M |
| Capital Expenditures | -$2.21M | -$1.06M |
| Free Cash Flow | -$113.87M | -$20.28M |
| FCF Per Share | -$1.18 | -$0.41 |
Efficiency
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Asset Turnover | 0.20 | 0.38 |
| Revenue Per Employee | $1.61M | $398.96K |
| Profits Per Employee | -$1.21M | -$732.08K |
| Employee Count | 145 | 73 |
Dividends and yields
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -5.36% | -21.2% |
| FCF Yield | -3.49% | -7.64% |
Shares
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 96,489,500 | 59,128,900 |
| Shares Change (YoY) | 2.46% | 11.1% |
| Shares Change (QoQ) | 9.70% | 0.54% |
| Float | 95,686,700 | 48,744,500 |
| Shares Held by Insiders | 0.83% | 11.8% |
| Shares Held by Institutions | 106.0% | 59.4% |
Taxes
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Income Tax | $0 | $91.50K |
Scores
| Measure | IDEAYA Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | 17.00 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from IDEAYA Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.